MoonLake Immunotherapeutics Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
MoonLake Immunotherapeutics quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q1 2022.
  • MoonLake Immunotherapeutics Nonoperating Income (Expense) for the quarter ending March 31, 2022 was $7.77K, a 56.4% decline year-over-year.
  • MoonLake Immunotherapeutics Nonoperating Income (Expense) for the twelve months ending March 31, 2022 was $17.7K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $17.7K $7.77K -$10K -56.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $27.7K $2.26K Oct 1, 2021 Dec 31, 2021 10-K 2022-02-17
Q3 2021 $1.48K Jul 1, 2021 Sep 30, 2021 10-Q/A 2021-12-14
Q2 2021 $6.14K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $17.8K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.